Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Adherence interventions and outcomes of tuberculosis treatment: A systematic review and meta-analysis of trials and observational studies
Background Incomplete adherence to tuberculosis (TB) treatment increases the risk of
delayed culture conversion with continued transmission in the community, as well as …
delayed culture conversion with continued transmission in the community, as well as …
Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis
Multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis are generally
thought to have high mortality rates. However, many cases can be treated with the right …
thought to have high mortality rates. However, many cases can be treated with the right …
Delamanid for multidrug-resistant pulmonary tuberculosis
MT Gler, V Skripconoka… - … England Journal of …, 2012 - Mass Medical Soc
Background Delamanid (OPC-67683), a nitro-dihydro-imidazooxazole derivative, is a new
antituberculosis medication that inhibits mycolic acid synthesis and has shown potent in vitro …
antituberculosis medication that inhibits mycolic acid synthesis and has shown potent in vitro …
Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis
Although progress has been made to reduce global incidence of drug-susceptible
tuberculosis, the emergence of multidrug-resistant (MDR) and extensively drug-resistant …
tuberculosis, the emergence of multidrug-resistant (MDR) and extensively drug-resistant …
Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients
SD Ahuja, D Ashkin, M Avendano, R Banerjee… - 2012 - journals.plos.org
Background Treatment of multidrug resistant tuberculosis (MDR-TB) is lengthy, toxic,
expensive, and has generally poor outcomes. We undertook an individual patient data meta …
expensive, and has generally poor outcomes. We undertook an individual patient data meta …
WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update
D Falzon, E Jaramillo, HJ Schünemann, M Arentz… - 2011 - publications.ersnet.org
The production of guidelines for the management of drug-resistant tuberculosis (TB) fits the
mandate of the World Health Organization (WHO) to support countries in the reinforcement …
mandate of the World Health Organization (WHO) to support countries in the reinforcement …
Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement
C Lange, I Abubakar, JWC Alffenaar, G Bothamley… - 2014 - publications.ersnet.org
The emergence of multidrug-resistant (MDR) and extensively drug-resistant (XDR)
tuberculosis (TB) substantially challenges TB control, especially in the European Region of …
tuberculosis (TB) substantially challenges TB control, especially in the European Region of …
Short, highly effective, and inexpensive standardized treatment of multidrug-resistant tuberculosis
Rationale: Based on expert opinion, the global guidelines for management of multidrug-
resistant tuberculosis impose lengthy and often poorly tolerated treatments. Objectives: This …
resistant tuberculosis impose lengthy and often poorly tolerated treatments. Objectives: This …
[HTML][HTML] New drugs and perspectives for new anti-tuberculosis regimens
Tuberculosis (TB) is the ninth cause of global death, more than any other infectious disease.
With growing drug resistance the epidemic remains and will require significant attention and …
With growing drug resistance the epidemic remains and will require significant attention and …
Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes
D Falzon, N Gandhi, GB Migliori… - European …, 2013 - publications.ersnet.org
A meta-analysis for response to treatment was undertaken using individual data of multidrug-
resistant tuberculosis (MDR-TB)(resistance to isoniazid and rifampicin) patients from 26 …
resistant tuberculosis (MDR-TB)(resistance to isoniazid and rifampicin) patients from 26 …